ABCL
Price
$3.72
Change
+$0.03 (+0.81%)
Updated
Dec 24 closing price
Capitalization
1.11B
61 days until earnings call
Intraday BUY SELL Signals
NKTR
Price
$43.94
Change
-$0.52 (-1.17%)
Updated
Dec 24 closing price
Capitalization
893.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs NKTR

Header iconABCL vs NKTR Comparison
Open Charts ABCL vs NKTRBanner chart's image
AbCellera Biologics
Price$3.72
Change+$0.03 (+0.81%)
Volume$1.72M
Capitalization1.11B
Nektar Therapeutics
Price$43.94
Change-$0.52 (-1.17%)
Volume$300.29K
Capitalization893.81M
ABCL vs NKTR Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. NKTR commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and NKTR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ABCL: $3.72 vs. NKTR: $43.94)
Brand notoriety: ABCL: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 41% vs. NKTR: 35%
Market capitalization -- ABCL: $1.11B vs. NKTR: $893.81M
ABCL [@Biotechnology] is valued at $1.11B. NKTR’s [@Biotechnology] market capitalization is $893.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, NKTR is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 4 bearish.
  • NKTR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ABCL and NKTR are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +11.04% price change this week, while NKTR (@Biotechnology) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 24, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.11B) has a higher market cap than NKTR($894M). NKTR YTD gains are higher at: 214.982 vs. ABCL (26.962). NKTR has higher annual earnings (EBITDA): -86.05M vs. ABCL (-212.36M). ABCL has more cash in the bank: 496M vs. NKTR (270M). NKTR has less debt than ABCL: NKTR (91.9M) vs ABCL (142M). NKTR has higher revenues than ABCL: NKTR (62.6M) vs ABCL (35.3M).
ABCLNKTRABCL / NKTR
Capitalization1.11B894M125%
EBITDA-212.36M-86.05M247%
Gain YTD26.962214.98213%
P/E RatioN/AN/A-
Revenue35.3M62.6M56%
Total Cash496M270M184%
Total Debt142M91.9M155%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLNKTR
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
NKTR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTNX395.702.44
+0.62%
Rydex S&P 500 2x Strategy H
GWEZX34.050.13
+0.38%
AMG GW&K Small Cap Core Z
LEQIX13.420.02
+0.15%
LoCorr Dynamic Opportunity I
FZAPX94.17N/A
N/A
Fidelity Advisor Stock Sel Z
HCMIX36.29N/A
N/A
HCM Tactical Plus I

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with ABSI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.81%
ABSI - ABCL
58%
Loosely correlated
+1.14%
RXRX - ABCL
58%
Loosely correlated
+0.92%
CRSP - ABCL
57%
Loosely correlated
+0.44%
VCYT - ABCL
56%
Loosely correlated
-0.35%
DNA - ABCL
51%
Loosely correlated
+1.60%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-1.17%
AMLX - NKTR
42%
Loosely correlated
+1.46%
SLS - NKTR
42%
Loosely correlated
+2.53%
EYPT - NKTR
37%
Loosely correlated
-0.65%
DNTH - NKTR
36%
Loosely correlated
+1.27%
ABCL - NKTR
33%
Loosely correlated
+0.81%
More